Navigation Links
2013 ISPE Facility of the Year Awards Program Names Novartis's United States Flu Cell Culture Facility as Overall Winner
Date:11/4/2013

TAMPA, Fla., Nov. 4, 2013 /PRNewswire-USNewswire/ -- ISPE announced during the Plenary Session at its 2013 Annual Meeting in Washington, D.C. USA, that Novartis's United States Flu Cell Culture Facility is the Overall Winner of the 2013 Facility of the Year Awards (FOYA) program.

(Logo:  http://photos.prnewswire.com/prnh/20120912/DC73253LOGO )

Novartis's United States Flu Cell Culture Facility in Holly Springs, North Carolina, USA represents a breakthrough use of innovative technology and development of a large scale manufacturing process to produce seasonal and pandemic influenza vaccines. This innovative process breaks with the 50-year tradition of utilizing eggs for the method of growing the virus in favor of a ground-breaking cell culture technology that offers many potential advantages over the traditional manufacturing process for flu vaccines. These advantages include process raw materials that are readily available and not threatened by pandemic events and closed-system bioreactors that reduce the required biosafety level for the manufacturing space.

The proprietary technology at Novartis's United States Flu Cell Culture Facility enables flexible and fast start-up of vaccine manufacturing, offering rapid response to potential pandemic influenza threats while fulfilling the need for seasonal influenza vaccines. This project introduces a promising new path for vaccine production, and exemplifies the type of advancements in pharmaceutical and biotechnology manufacturing technology that the FOYA program seeks to recognize. In honor of this accomplishment, Novartis is named the 2013 Facility of the Year Awards Overall Winner

More information about Novartis's winning project, as well as the Facility of the Year Awards program in general, can be found at www.FacilityoftheYear.org.

About the Facility of the Year Awards Program
Sponsored by ISPE, the Facility of the Year Awards (FOYA) program recognizes state-of-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high-quality medicines. Now in its tenth year, the awards program effectively spotlights the accomplishments, shared commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of all global consumers.

For more information, contact:

DANIELLE HOULD
ISPE Membership Marketing Communications Manager
+1-813-960-2105
dhould@ispe.org 
www.ISPE.org


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi Manufacturing Facility Passes FDA Inspection
2. Comprehensive Care Corporation Announces Extension of $5 Million Credit Facility
3. SynergEyes Reports Minor Interruption at Manufacturing Facility
4. SRI International Completes Biosciences Facility Expansion in Shenandoah Valley, Virginia
5. Harlan Laboratories Continues Strategic Growth with Expansion of South European Services Facility
6. TPI Facility Received Official GMP Certificate
7. Piramal
8. Healthcare to Invest $ 11 Million in Hormonal Healthcare Production at its Morpeth, UK, Facility
9. US Representative Mike Fitzpatrick Tours US BioDesign Manufacturing Facility
10. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
11. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):